Loading...
XJPX
2385
Market cap42mUSD
Dec 05, Last price  
254.00JPY
1D
-0.78%
1Q
29.59%
Jan 2017
-7.97%
IPO
-91.74%
Name

Soiken Holdings Inc

Chart & Performance

D1W1MN
XJPX:2385 chart
P/E
—
P/S
1.37
EPS
—
Div Yield, %
1.97%
Shrs. gr., 5y
—
Rev. gr., 5y
-12.24%
Revenues
4.85b
-6.01%
2,547,236,0001,980,355,0001,443,912,0001,520,121,0001,548,483,0001,966,277,0002,342,997,0002,548,899,0003,213,081,0004,147,858,0005,455,043,0007,568,171,0009,312,499,0008,942,496,0009,347,879,0008,079,926,0005,158,458,0004,848,534,000
Net income
-211m
L-68.18%
-95,927,000-163,078,000-1,145,236,000-284,987,000-184,141,00069,549,00026,025,000-5,519,00046,709,000186,569,000197,978,000553,467,000731,686,000562,061,000809,710,000451,847,000-662,203,000-210,696,000
CFO
558m
P
66,822,000-208,347,000-631,740,000-212,167,000-207,148,00086,363,000-65,191,000-71,883,000190,561,000133,500,000-74,034,000469,427,000829,558,000-107,441,0002,135,970,000-101,554,000-880,822,000557,955,000
Dividend
Jun 27, 20245 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Soiken Holdings Inc. engages in the development of biomarkers in Japan. The company is involved in the development and sale of cosmetics and dietary supplements; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for physician-led pharmaceutical clinical research, health checkups, and specific health guidance; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. Soiken Holdings Inc. was incorporated in 1994 and is headquartered in Toyonaka, Japan.
URL
https://www.soiken.com/
IPO date
Dec 18, 2003
Employees
100
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT